What we have learned about the health-care delivery industry through the COVID-19 pandemic. The goal is to offer provocative opinions, based on real world data, on what we did
Update on ECMO for COVID-19: What have we learned? Early experience of pump-controlled retrograde trial off for weaning from (VA ECMO) in adult patients with cardiogenic shock
Healthcare Workers (HCW) are exposed daily to a host of infectious diseases within the hospital and patient care environments. Infection rates of HCWs. Vasoplegia
Look at the Coronavirus (SARS-CoV-2) Pandemic and where we are now, what we learned, got right, got wrong and how escalating therapy's vis a vis, ECMO helped
Published data along with our own experiences with the critical risk factors affecting survival with COVID-19 when ECMO was required as a supportive therapy